Sonoma Pharmaceuticals (NASDAQ:SNOA) Issues Earnings Results, Beats Estimates By $0.19 EPS

Sonoma Pharmaceuticals (NASDAQ:SNOA) issued its quarterly earnings results on Tuesday. The company reported $0.09 EPS for the quarter, topping analysts’ consensus estimates of ($0.10) by $0.19, Zacks reports. The company had revenue of $7.17 million during the quarter, compared to analysts’ expectations of $5.29 million. Sonoma Pharmaceuticals had a negative return on equity of 5.44% and a negative net margin of 7.65%.

Sonoma Pharmaceuticals Stock Down 0.8%

Shares of NASDAQ SNOA traded down $0.01 during midday trading on Thursday, reaching $1.23. 32,004 shares of the stock were exchanged, compared to its average volume of 114,102. The firm has a market cap of $5.89 million, a price-to-earnings ratio of -1.35 and a beta of 1.31. The firm has a 50-day simple moving average of $1.21 and a two-hundred day simple moving average of $1.64. Sonoma Pharmaceuticals has a twelve month low of $0.85 and a twelve month high of $3.95.

Analysts Set New Price Targets

Separately, Weiss Ratings lowered Sonoma Pharmaceuticals from a “sell (d-)” rating to a “sell (e+)” rating in a report on Friday, August 21st. One equities research analyst has rated the stock with a Sell rating. According to data from MarketBeat, Sonoma Pharmaceuticals presently has an average rating of “Sell”.

Sonoma Pharmaceuticals Company Profile

Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing, manufacturing and commercializing non-antibiotic and non-steroidal products for human and animal health. Its products are designed for applications including dermatology, wound care, eye care and veterinary treatment. The company’s product portfolio is based primarily on Microcyn technology, a stabilized hypochlorous acid solution intended to cleanse, debride and manage wounds and various skin conditions. Products marketed under the company’s brands have included Dermacyn, for wound and skin care, and Ocucyn, for ophthalmic care, along with veterinary products and other prescription and over-the-counter formulations.